NxStage Medical, Inc.NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...

Missing dialysis treatments can be a matter of life and death for patients with end-stage renal disease (ESRD). However, the portability of the System One allows home patients to take their machines ...

Medical device firm NxStage Medical Inc. says that it has raised $43 million through private placement of its common stock and warrants. Officials at Lawrence-based NxStage (Nasdaq: NXTM) said the ...